Description
An inhibitor of menin-MLL fusion protein interactions (IC50 = 648 nM); binds to menin (Kd = 201 nM) and inhibits the menin-MLL-AF9 interaction in HEK293 cells; inhibits growth of mouse BMCs expressing the Hoxa9 transformation-dependent MLL fusion proteins MLL-AF9 or MLL-ENL (IC50 = 5 µM for both); inhibits growth of human leukemia cell lines containing MLL translocations
Formal name: 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)-thieno[2,3-d]pyrimidine
Synonyms:
Molecular weight: 375.6
CAS: 1271738-59-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Transcription Factors